Deferasirox oral
Deferasirox is a generic prescription medication used to treat iron overload in patients with conditions like thalassemia. It works by binding to excess iron and helping the body remove it through urine. Available as oral granules in 90mg, 180mg, and 360mg strengths, manufactured by Ascend Laboratories, LLC. This information was generated using AI and is provided for informational and research purposes only.
Complete Metadata
| @type | dcat:Dataset |
|---|---|
| accessLevel | public |
| accrualPeriodicity | R/P1Y |
| bureauCode |
[
"009:10"
]
|
| contactPoint |
{
"fn": "Division of Drug Information",
"@type": "vcard:Contact",
"hasEmail": "mailto:druginfo@fda.hhs.gov"
}
|
| description | Deferasirox is a generic prescription medication used to treat iron overload in patients with conditions like thalassemia. It works by binding to excess iron and helping the body remove it through urine. Available as oral granules in 90mg, 180mg, and 360mg strengths, manufactured by Ascend Laboratories, LLC. This information was generated using AI and is provided for informational and research purposes only. |
| distribution |
[
{
"@type": "dcat:Distribution",
"title": "Deferasirox oral",
"mediaType": "text/html",
"description": "
Access the FDA dataset for Deferasirox oral — ANDA 213374 submitted by Mylan Institutional LLC
",
"downloadURL": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=213374"
}
]
|
| identifier | ANDA213374 |
| issued | 2016-09-16 |
| keyword |
[
"drug",
"drug-information",
"drug-manufacturers",
"fda",
"prescription-drugs"
]
|
| landingPage | https://www.fda.gov/drugs |
| license | https://open.fda.gov/license |
| modified | 2025-03-17 |
| programCode |
[
"009:002"
]
|
| publisher |
{
"name": "U.S. Food and Drug Administration",
"@type": "org:Organization"
}
|
| theme |
[
"FDA"
]
|
| title | Deferasirox oral |
